NCT04107584Unknown不适用
Prognostic Value of Plasma Biomarkers Among Patients With Hypertension
Beijing Institute of Heart, Lung and Blood Vessel Diseases1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2017年4月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- Primary mortality of hypertension
研究概览
简要总结
Hypertension is the most important risk factor for cardiovascular and cerebrovascular diseases，and also a substantial public health problem. The purpose of the study is to investigate the association between plasma biomarkers and adverse outcomes in patients with hypertension.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •>18 years old
- •In accordance with the diagnosis of hypertension (BP≥140/90mmHg)
排除标准
- •The exclusion Criteria for the study program were as follows:
- •Pregnancy, history of heart failure or left ventricular ejection fraction less than 40%, myocardial infarction within one month, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting, cerebrovascular disease, severe liver disease, severe chronic renal failure (eGFR less than 30 mL/min/1.73 m2) in the past three months.
结局指标
主要结局
Primary mortality of hypertension
时间窗: Through study completion, an average of 2 years
The incidence rate of primary mortality of hypertension
次要结局
- Secondary outcomes of heart(Through study completion, an average of 2 years)
- Secondary outcomes of brain(Through study completion, an average of 2 years)
- Secondary outcomes of kidney(Through study completion, an average of 2 years)
- Secondary outcomes of eyes(Through study completion, an average of 2 years)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Prognostic Risk of Patients With Essential Hypertension for Cardiovascular Events (PROSPECT)Essential HypertensionNCT03708601Beijing Institute of Heart, Lung and Blood Vessel Diseases3,000
招募中
不适用
A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)Cardiovascular DiseasesHypertensionNCT04212455Guangdong Provincial People's Hospital50,000
招募中
不适用
Plasma Biomarker in Amblyopia PatientsAmblyopiaNCT05705778Zhongshan Ophthalmic Center, Sun Yat-sen University600
招募中
不适用
The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.Primary HypertensionObesityNCT06208072Hippocration General Hospital50
已完成
不适用
Pulmonary Hypertension and ImatinibPAHNCT01092897The Cleveland Clinic130